Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
New data shows GLP-1 drugs are safe for pregnancy and heart devices work in kidney patients.
Today's news focuses on safety and support for people with kidney disease. The strongest evidence confirms that common diabetes drugs are safe during pregnancy. Other studies show that heart devices and exercise programs can help manage symptoms, though these groups were small. A new care model in China also showed better results for home dialysis patients.
Pregnancy and perinatal outcomes following exposure to GLP-1 and dual GLP-1/GIP receptor agonists: a time-window-stratified systematic review and meta-analysis.
This review combined data from many studies to check the safety of GLP-1 drugs during pregnancy. It looked at how these drugs affect the mother and baby. This is a meta-analysis, which is the strongest type of evidence.
Effects of a Nurse-Led Multicomponent Exercise Intervention for Haemodialysis Patients With Possible or Confirmed Sarcopenia: A Cluster Randomised Trial.
This trial tested a 12-week exercise program for 56 dialysis patients with muscle loss. The program was led by nurses. It aimed to improve muscle strength and quality of life. The study is small, but it shows exercise can help these patients.
Subcutaneous Defibrillator for Primary Prevention in Chronic Kidney Disease Stage 3-5: The Single-Arm STEADIED Study.
This study tested a heart device in 39 people with kidney disease. The device is meant to stop sudden heart attacks. The study ended early, so it is small. It shows the device works in this group, but more people are needed to be sure.
Serial Urinary Albumin-to-Creatinine Ratio as an Early Predictor of 28-Day Mortality and Organ Dysfunction in Critically Ill Patients with Sepsis: A Prospective Observational Study
This study found that high protein in the urine predicts a higher risk of death in sick patients. It looked at 250 people in the ICU. This is an observational study, so it shows a link, not proof of cause.
The Guangzhou Model of Peritoneal Dialysis Care: A Scalable Hub-and-Satellite Network.
This study looked at a new way to manage home dialysis in China. It used a hub-and-satellite model with 122 centers. Patients in this network had better long-term health outcomes. This is an observational study, so it shows a link, not proof of cause.
Association Between Understanding Health Literature in English and Optimal Preparation for Dialysis Initiation: An Observational Cohort Study
This study found that people who do not read English well are less likely to choose home dialysis or a transplant. It shows a link between language skills and treatment choices. This is an observational study, so it shows a link, not proof of cause.
Stochasticity in response to rostrocaudal and mediolateral determinants influences inaccurate specification within kidney organoids.
This study looked at how stem cells form kidney tissue in the lab. It found that the cells sometimes form the wrong types of tissue. This was in cells, not people yet.
Empagliflozin's role in cardiometabolic disease treatment: an Egyptian expert's view.
This review looks at how empagliflozin works for heart and kidney disease in Egypt. It summarizes existing studies and guidelines. There are no new results from this paper.
Clinical Trials: A Call for Collaboration Between Pediatrics and Internal Medicine
This article calls for better teamwork between child and adult doctors. It aims to speed up drug approval for children with kidney disease. There are no results yet.